PictorLabs, Inc. is a digital pathology company developing an AI-powered virtual staining platform to revolutionize histopathology and accelerate clinical research with the goal of improving patient outcomes. Led by a team with deep expertise in bioengineering, artificial intelligence, and health-tech product development, the Company is reimagining existing histopathology workflows, accelerating clinical and diagnostic results, and improving process sustainability. From a single unstained tissue sample, PictorLabs’ proprietary platform can produce an unlimited number of virtual stains that are indistinguishable from analogous chemical stains. PictorLabs is developing products that replicate standard of care stains and is creating specialized virtual biomarker stains for indications in which there is a large demand for novel and accelerated diagnostic tests. To learn more, visit https://pictorlabs.ai/
Location: United States, California, Los Angeles
Employees: 11-50
Total raised: $67.6M
Founded date: 2019
Funding Rounds 3
| Date | Series | Amount | Investors |
| 25.09.2024 | Series B | $30M | - |
| 12.12.2022 | - | $18.8M | - |
| 12.01.2022 | - | $18.8M | - |
Mentions in press and media 10
| Date | Title | Description |
| 26.09.2024 | PictorLabs Secures $30 Million to Revolutionize Histopathology | In the bustling world of medical technology, PictorLabs stands out like a lighthouse in a storm. This Los Angeles-based software company has just raised $30 million in Series B funding, a significant boost that promises to reshape the lands... |
| 25.09.2024 | PictorLabs: UCLA Virtual Staining Technology Spin Out Secures $30 Million (Series B) | PictorLabs, a software company transforming histopathology with AI-based virtual staining, announced the successful completion of its $30 million Series B funding round. This funding round was led by global software investor Insight Partner... |
| 18.09.2024 | PictorLabs Raises $30M in Series B Funding | PictorLabs, a Los Angeles, CA-based software company transforming histopathology with AI-powered virtual staining, raised $30M in Series B funding. The round was led by Insight Partners, with participation from M Ventures. The company inten... |
| 09.04.2024 | PredxBio and PictorLabs Forge Strategic Partnership to Advance Cancer Research and Diagnostics with Next Generation Spatial Analytics | PredxBio and PictorLabs Forge Strategic Partnership to Advance Cancer Research and Diagnostics with Next Generation Spatial Analytics PredxBio, Inc., a leader in spatially intelligent biology, and PictorLabs, Inc., a leading digital patholo... |
| 12.12.2022 | PictorLabs Launches with More Than $18 Million in Funding | - |
| 05.12.2022 | PictorLabs Raises $15.2M in Funding | PictorLabs, a Los Angeles, CA-based digital pathology company, raised $15.2M in funding. The round was led by M Ventures, SCC Soft Computer, and Koç Holding. The company intends to use the funds to expand its biomarker portfolio, develop no... |
| 02.12.2022 | Bringing AI to histopathology, PictorLabs launches with $15.2M | The company uses AI to virtually stain tissue samples Histopathology refers to microscopic examination of tissue, used to study the manifestations of disease. Historically, this process had involved complex chemical-based tissue staining, w... |
| 01.12.2022 | PictorLabs Launches with More Than $18.8 Million to Advance Transformative Virtual Staining | PictorLabs, Inc., a digital pathology company developing an AI-powered virtual staining platform to revolutionize histopathology and accelerate clinical research with the goal of improving patient outcomes, announced its launch with the com... |
| 01.12.2022 | PictorLabs Launches With $15.2M | LOS ANGELES, CA, PictorLabs today announced its launch with the completion of a $15.2 million financing round. >> Click here for more funding data on PictorLabs >> To export PictorLabs funding data to PDF and Excel, click he... |
| 12.01.2022 | UCLA Spinout PictorLabs Launches with $18.8M to Revolutionize Histopathology | What You Should Know: |